ROLE OF HLA GENES IN DEVELOPMENT OF HLA-ALLOIMMUNIZATION IN BLOOD RECIPIENTS

A genetically determined predisposition to the development of HLA-alloimmunization as a result of blood transfusions is associated with the presence of HLA-alleles DRB1*04, DQA1*03:01, DQA1*05:01 and HLA-haplotype DRB1*04-DQA1*03:01-DQB1*03:02 in the genotypes of recipients. The risk of antibody production is reduced in patients with HLA-alleles DRB1*16, DQA1*01:02, DQB1*05:02 and HLA-haplotype DRB1*16-DQA1*01:02-DQB1*05:02.

Shaz B.H., Hillyer C.D., Reyes G.M. Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects. 3rd ed. Philadelphia, PA: Elsevier; 2018.

Mineeva N.V., Krobinets I.I., Blinov M.N., Kapustin S.I. Platelet antigens and antibodies. Literature review. Onkogematologiya. 2013; 8(3): 60-8. (in Russian)

Butina E.V., Sherstnev F.S., Maksimov O.D., Zaytseva G.A., Poponina E.A., Yovdiy A.V. et al. Technical and organizational aspects of prophylaxis of HLA-alloimmunization and platelet refractoriness in hematological patients. Transfuziologiya. 2018; 19(4): 59-66. (in Russian)

Chechetkin A.V., Bessmeltsev S.S., Kiseleva E.A., Kasyanov A.D., Danilchenko V.V. The quality of platelet concentrates and erythrocyte suspension obtained by apheresis method with a multicomponent donation. Medline.ru. Rossiyskiy biomeditsinskiy zhurnal. 2019; 20(1): 156-65. (in Russian)

Eihler O.V., Chechetkin A.V., Ajigitova E.V., Danilchenko V.V., Mineeva N.V., Krobinets I.I. et al. Characteristics of transfusion reactions and complications in medical organizations of the Russian Federation in 2019. Transfuziologiya. 2020; 21(4): 304-12. (in Russian)

Rakhmani A.F., Mikhaylova E.A., Dubinkin I.V., Kalmykova O.S., Galuzyak V.S., Troitskaya V.V. et al. Refractoriness to donor platelets transfusion in patients with aplastic anemia and hemoblastosis. Onkogematologiya. 2018; 13(2): 62-72. (in Russian)

Murphy M., Roberts D., Yazer M. Practical Transfusion Medicine. 5th ed. Oxford, UK: Wiley-Blackwell; 2017.

Weinstock С., Schnaidt M. Human Leucocyte Antigen sensitisation and its impact on transfusion practice. Transfus. Med. Hemother. 2019; 46(5): 356–69.

Wang J., Xia W., Deng J., Xu X., Shao Y., Ding H. et al. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness. Transfus. Med. 2018; 28(1): 40-6.

Basire A., Picard C. Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness. Transfus. Clin. Biol. 2014; 21(4-5): 193-206.

Delbos F., Cesbron A. Caracterization of HLA allo-immunization and clinical impact in transfusion and organ transplantation. Transfus. Clin. Biol. 2017; 24(3): 131-7.